GVC Launches ‘Changing for the Bettor’ Safer Gambling Campaign and Announces Major Research Collaboration

Jay DossetterNews

23 January 2019

GVC Holdings PLC
(“GVC”, the “Group”)

GVC Launches ‘Changing for the Bettor’ Safer Gambling Campaign and Announces Major Research Collaboration

GVC Holdings PLC (LSE: GVC), the multinational sports betting and gaming group, has today announced a global responsible gambling campaign, Changing for the Bettor, which is being spearheaded by a major new research project into problem gambling with the Division on Addiction, Cambridge Health Alliance, a Harvard Medical School teaching hospital.

The guiding principle of Changing for the Bettor is to further establish GVC as the most trusted and enjoyable betting operator in the world.  The campaign comprises of seven pillars, each of which have substantive projects attached:

  1. Understanding the problem and best solutions – Including today’s announcement of a five-year, multi-million pound research project with the Division on Addiction, Cambridge Health Alliance, a Harvard Medical School teaching hospital (further details below).
  2. Educating our key stakeholders – Including the national roll out of youth education programmes with the charity GamCare in the UK – the largest project of its kind in the UK, as well as a state-school awareness campaign with EPIC Risk Management.
  3. Promoting responsible attitudes – Leading the industry in recently agreeing a ban on pre-watershed gambling adverts on television, around live sports.
  4. Empowering customers – Rolling out a ‘markers of harm’ algorithm to all UK facing parts of the business.
  5. Funding treatment for those in need – Doubling our donation to research, education and treatment on problem gambling to 0.2% of gross gaming revenue (GGR).
  6. Championing responsible product design – Developing more responsible product design principles.
  7. Drive cultural change within our business – Ensuring that a safer gambling approach underpins all aspects of our business. Accordingly we are working in consultation with the Safer Online Gambling Group.

Fundamental to GVC’s commitment to better understand and reduce the potential for problem gambling behaviour to develop will be investment in rigorous research. Accordingly, the Group will be investing $5 million into a new partnership with Harvard Medical School faculty at the Division on Addiction over the next five years.  GVC will provide Harvard faculty at the Division with access to anonymised player data across a range of its brands, sports betting, and gaming products.

The research will be broad ranging, focusing on a number of areas including, but not limited to:

  • Patterns of normal internet gambling behaviour
  • Behavioural markers of gambling problems among internet players generally and on specific betting and game types
  • Cross-product analyses
  • Cross-brand analyses
  • The effects of the expansion of gambling in new markets

Within this approach, researchers will seek to evaluate the effectiveness of algorithms used by GVC and other operators to detect at-risk behaviours, assess the effectiveness of intervention messaging and the impact of operator’s responsible gaming tools.

Commenting on the announcement, GVC’s Director of Responsible Gaming, Grainne Hurst said:

“Whilst the vast majority of our customers enjoy playing with us in a safe and fun environment we are aware that for some players, gambling can impact their lives negatively. We are committed to leading the industry in minimising potential harm caused by problem gambling. That is why we are today launching Changing for the Bettor and have partnered with Harvard faculty at the Division on Addiction to help us to better understand and tackle the issues around problem gambling.”

Mims Davies MP the UK’s Gambling Minister, said:

“Gambling operators have a key role to play in protecting people from harm and identifying potentially risky betting behaviour. Research is essential to progress in this area and GVC's 'Changing for the Bettor' campaign will make an important contribution to tackling problem gambling. We are committed to protecting consumers across the country and are working with industry to create a healthy and more socially responsible sector.”

Dr. Howard Shaffer, Morris E. Chafetz Associate Professor of Psychiatry in the Field of Behavioural Sciences, Harvard Medical School and Director, Division on Addiction added:

“It is only by taking an evidence-based approach to examining gambling that we can develop better strategies and tools to limit its potential to cause harm. The collaboration with GVC that we have announced today will play a significant role in advancing our knowledge about gambling and intemperate gambling and is warmly welcomed.”

- Ends -


 For further information:

Investor Relations

Nick Batram, Director of Investor Relations & External Communications

Paul Tymms, Head of Investor Relations


Media enquiries:

Jay Dossetter

Head of CSR & Corporate Communications


Notes to editors

About GVC
GVC Holdings PLC is one of the world’s largest sports betting and gaming groups, operating both online and in the retail sector.  The Group owns a comprehensive portfolio of established brands; Sports Brands include bwin, Coral, Crystalbet, Eurobet, Ladbrokes and Sportingbet; Gaming Brands include CasinoClub, Foxy Bingo, Gala, Gioco Digitale, partypoker and PartyCasino. The Group owns proprietary technology across all of its core product verticals and in addition to its B2C operations provides services to a number of third-party customers on a B2B basis. GVC acquired Ladbrokes Coral Group plc on 28 March 2018 and is now the UK’s largest high street bookmaker, with over 3,500 betting shops.  The Group, incorporated in the Isle of Man, is a constituent of the FTSE 100 index and has licences in more than 20 countries, across five continents. GVC was a founding member of the Senet Group and is committed to leading the industry in Responsible Gambling standards.

For more information see the Group's website: www.gvc-plc.com

About Division on Addiction
Our mission is to alleviate addiction-related social, medical, and economic burdens through research, education, training, and outreach. We offer encouragement, education, and training to a diverse group, including health care providers, policy makers, and scientists. The Division was founded at the Harvard Medical School 25 years ago. We are part of the Department of Psychiatry at the Cambridge Health Alliance, a Harvard Medical School teaching hospital. Our faculty and staff come from diverse professional backgrounds helping us to expand our understanding, prevention, and treatment of addiction. We are funded through a variety of private and public agencies, businesses, and foundations. Those interested in joining our team, should review our latest fellowship and job opportunities.

For more information see: https://www.divisiononaddiction.org/